Literature DB >> 3317786

Expression of restricted immunoglobulin isotypes in plasmacellular hyperplasia after allogeneic bone marrow transplantation.

H J Schuurman1, R W Hendriks, L F Verdonck, J van Baarlen, G C de Gast, R K Schuurman.   

Abstract

Plasmacellular hyperplasia in lymphoid tissue was found in 4 out of 9 patients 1-6 months after allogeneic bone marrow transplantation as treatment for leukaemia. In the plasma cell populations, 13-85% expressed a single immunoglobulin light and heavy chain isotype (monotypic Ig expression). DNA analysis, using a DNA probe specific for heavy chain JH gene segments and for light chains, did not reveal the presence of clonally restricted B lymphocytes. The patients' sera lacked homogeneous immunoglobulins. We conclude that plasmacellular hyperplasia found after allogeneic bone marrow transplantation represents a polyclonal B-cell expansion- with a restriction in Ig isotype.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3317786     DOI: 10.1111/j.1365-3083.1987.tb02273.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Differential methylation at the 5' and the 3' CCGG sites flanking the X chromosomal hypervariable DXS255 locus.

Authors:  R W Hendriks; M E Kraakman; R G Mensink; R K Schuurman
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

2.  Antisera to human IgE can also recognize IgA and IgM molecules as produced by selected B lymphoblastoid cell lines.

Authors:  R W Hendriks; A Thompson; M E Kraakman; A L Drayer; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

3.  Polyclonal hyper-immunoglobulin G1(A1) syndrome. Evidence for a dominant immunoglobulin production regulator within the human immunoglobulin heavy chain gene complex.

Authors:  R W Hendriks; L A Sandkuyl; M E Kraakman; G G de Lange; R K Schuurman
Journal:  Hum Genet       Date:  1989-05       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.